OCULAR THERAPEUTIX, INC
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 15 CROSBY DRIVE, BEDFORD, MA, 01730
Mailing Address 15 CROSBY DRIVE, BEDFORD, MA, 01730
Phone 781-357-4000
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2025
-$80.74M
Net Income
$153.75M
Total Liabilities
$-1.42
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 10, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 10, 2026 | View on SEC |
| 8-K Current report of material events | February 5, 2026 | View on SEC |
| 10-K Annual financial report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 4, 2026 | View on SEC |
| 4 Insider stock transaction report | January 26, 2026 | View on SEC |
| 3 Initial insider ownership report | January 26, 2026 | View on SEC |
| 8-K Current report of material events | January 23, 2026 | View on SEC |
| 3 Initial insider ownership report | January 22, 2026 | View on SEC |
| 4 Insider stock transaction report | January 22, 2026 | View on SEC |
Annual Reports
10-K February 5, 2026
- Strong revenue growth for DEXTENZA®, with a 28% increase to $68.5 million in 2023.
- Reduced net loss year-over-year, improving from $148.9 million to $125.3 million.
Material Events
8-K Other December 5, 2025
High Impact
- OCULAR THERAPEUTIX, INC. filed an official report detailing its plans and significant regulatory hurdles for FDA approval of its key eye drug, AXPAXLI (OTX-TKI).
- AXPAXLI is a crucial product for treating wet age-related macular degeneration (wet AMD), and its success or failure will significantly impact the company's future.
Insider Trading
SELL 5 insiders
6 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.